Introduction Survival among people with HIV-associated cryptococcal meningitis (CM)
remains low, particularly among women, despite the currently optimal use of antifungal …

Understanding the host immune response during cryptococcal meningitis (CM) is of critical
importance for the development of immunomodulatory therapies. We profiled the …

The cerebrospinal fluid (CSF) immune responses in HIV-uninfected cryptococcal meningitis
(CM) have not been well studied. In this study, we aimed to explore the phenotype of CSF …

Cryptococcal meningitis (CM) is an opportunistic fungal infection associated with human
immunodeficiency virus (HIV) and other forms of immunosuppression. We lack a clear …

Background: Immune modulation may improve outcome in HIV-associated cryptococcal
meningitis. Animal studies suggest alternatively activated macrophages are detrimental but …

Background. Cryptococcal meningitis (CM) is a leading cause of HIV-associated mortality
globally. High fungal burden in cerebrospinal fluid (CSF) at diagnosis and poor fungal …

Background Cryptococcal meningitis can occur in persons with less-apparent
immunosuppression. We evaluated clinical characteristics and outcomes of persons with …

Abstract Background Cryptococcal Meningitis (CM) is a common opportunistic infection in
the late stage of acquired immunodeficiency syndrome (AIDS). Despite the wide use of …

Background. Cryptococcal meningitis (CM) is a leading cause of death in individuals
infected with human immunodeficiency virus (HIV). Identifying factors associated with …

Background Human immunodeficiency virus (HIV) infection with advanced
immunosuppression predisposes to cryptococcal meningitis (CM). We describe the …